We don't sell peptides. We don't make them.
We verify them.
Axiom Analytics exists because the peptide market has a trust problem. Vendors post screenshots of test results that could be from any product. Labs sell "basic" testing and upcharge for additional identity and quality measurements. Buyers are left without clear, independently attributable data showing whether the submitted article matches its declared identity, purity, and content.
We built Axiom to fix that. We test the determinations each order names - nothing is silently inferred or substituted - and we hold no financial stake in any product we test.
Our controlled catalog contains over 100 peptide compounds and blends, from well-known molecules like BPC-157, TB-500, and Semaglutide to research-grade blends and emerging synthetics. Catalog coverage supplies controlled identity and article context; the exact test criteria, material allocation, execution evidence, and reviewer authority remain frozen to each sample and face up through signing and release.
No conflicts
We don't cultivate, process, or hold stake in any product we test. Axiom is a fundamentally isolated entity: a secure, unbiased node in the supply chain.
Forensic methods
Controlled methods lock expected values, acceptance ranges, units, and sources face up. Instrument and analyst observations remain recorded observations, not protocol defaults.
Tamper-proof
Released reports are cryptographically sealed with their frozen method criteria and recorded observations. A changed released payload no longer matches its signature.
What we do, and what we don't
We DO
- ✓Accept and accession paid 4X, 8X, DX, Rapid DNA, and applicable USP microbial services
- ✓Keep Rapid microbial DNA distinct from USP <61> enumeration and USP <71> sterility culture
- ✓Show every protocol-defined expected value, acceptance range, unit, and source face up and locked at entry
- ✓Require USP <71>'s separate two-media container allocation and no less than 14 days of incubation
- ✓Publish only complete, actually performed results after independent review
- ✓Cryptographically seal every COA on release
- ✓Let anyone verify a report in 3 seconds
- ✓Maintain controlled catalog entries for 100+ peptide compounds and blends
- ✓Surface unresolved criteria, run evidence, or controls to our staff for resolution without closing custody, entry, signing, or release
We DON'T
- ×Sell peptides, SARMS, or research chemicals
- ×Own or invest in any retail brand
- ×Offer tiered testing with hidden add-ons
- ×Allow report alteration after publication
- ×Make claims beyond what the data shows
- ×Release results without independent review
Analytical techniques behind each determination
Analysis is allocated across Axiom's laboratory network. Each reported result requires the exact method, current calibration and controls, raw run provenance, and authorized review, wherever the work is performed.
Diode-array detection resolves the main peptide peak from every impurity across the full UV spectrum.
Tandem MS/MS confirms the molecule by precursor and product-ion transitions, not retention time alone.
Intact-mass confirmation alongside the tandem transition work.
Detects lead, arsenic, cadmium and mercury down to parts per billion.
How we protect report integrity
The release software is designed to keep criteria and observations attributable, immutable, and reviewable.
Controlled observation entry
Protocol constants are locked from the frozen plan. Analysts or qualified integrations record observations and raw-artifact references; the system does not fabricate instrument output.
Cryptographic fingerprinting
Every report is hashed and signed the instant it's released. Change a single digit and the signature breaks. Anyone can verify this independently.
Independent verification
Your customers don't need to trust us. They enter the report number on our site and the math confirms the data is genuine, in three seconds.
Who we serve
Research vendors
Peptide suppliers who need independent, defensible COAs to differentiate from competitors making unverified claims.
Laboratories & quality teams
Teams reviewing independently measured identity, purity, and content data. Axiom reports are research-use-only and are not clinical safety, diagnostic, or treatment advice.
Quality-conscious buyers
End consumers who want to verify that what they ordered matches what they received, without trusting a screenshot.
How your report gets signed
The release workflow requires authenticated analyst, technical-reviewer, and lab-director approval before a certificate can be released. Samples may be accepted and queued first; missing method evidence, criteria, controls, or observations are surfaced to our staff for resolution and do not block entry, signing, or release. Missing reviewer authorization remains an authorization boundary.
Lab Analyst
Runs the methods frozen in the order against its controlled submitted-material allocation and records the primary instrument data behind the report.
Technical Reviewer
Independently audits the raw instrument data and methods before anything can be signed.
Lab Director
Holds final release authority and signs off under our documented quality system.
Role names and software controls are not personnel qualifications. A release may identify only the actual authorized reviewers whose current training, role authority, and signatures are bound to that record; the application does not manufacture those facts.
Ask us anything about the work
Methods, what a result means, whether we can test something unusual. You reach the people who run the bench, not a call centre. A chat becomes a tracked support thread when it ends, so nothing said in it is lost.